The Fort Worth Press - FriskaAi and Dexcom Enter CGM Data Integration Agreement

USD -
AED 3.672504
AFN 63.503991
ALL 83.192586
AMD 375.730804
ANG 1.790083
AOA 917.000367
ARS 1385.503978
AUD 1.450747
AWG 1.8
AZN 1.70397
BAM 1.693993
BBD 2.007535
BDT 122.298731
BGN 1.709309
BHD 0.376597
BIF 2960.807241
BMD 1
BND 1.28353
BOB 6.91265
BRL 5.255304
BSD 0.996752
BTN 94.473171
BWP 13.741284
BYN 2.966957
BYR 19600
BZD 2.004591
CAD 1.38985
CDF 2282.50392
CHF 0.795017
CLF 0.023433
CLP 925.260396
CNY 6.91185
CNH 6.92017
COP 3662.985579
CRC 462.864319
CUC 1
CUP 26.5
CVE 95.504742
CZK 21.309304
DJF 177.489065
DKK 6.492704
DOP 59.330475
DZD 133.010264
EGP 52.642155
ERN 15
ETB 154.083756
EUR 0.866104
FJD 2.257404
FKP 0.752712
GBP 0.750441
GEL 2.680391
GGP 0.752712
GHS 10.921138
GIP 0.752712
GMD 73.503851
GNF 8739.335672
GTQ 7.62808
GYD 208.64406
HKD 7.82615
HNL 26.46399
HRK 6.545204
HTG 130.656966
HUF 338.020388
IDR 16990.8
ILS 3.13762
IMP 0.752712
INR 94.850204
IQD 1305.703521
IRR 1313250.000352
ISK 124.760386
JEP 0.752712
JMD 156.892296
JOD 0.70904
JPY 160.28704
KES 129.470356
KGS 87.450384
KHR 3992.031527
KMF 428.00035
KPW 900.00296
KRW 1508.00035
KWD 0.30791
KYD 0.830627
KZT 481.867394
LAK 21678.576069
LBP 89256.247023
LKR 313.975142
LRD 182.893768
LSL 17.115586
LTL 2.95274
LVL 0.60489
LYD 6.362652
MAD 9.315751
MDL 17.507254
MGA 4153.999394
MKD 53.388766
MMK 2098.832611
MNT 3571.142668
MOP 8.042181
MRU 39.797324
MUR 46.770378
MVR 15.450378
MWK 1728.292408
MXN 18.122104
MYR 3.924039
MZN 63.950377
NAD 17.115586
NGN 1383.460377
NIO 36.680958
NOK 9.70286
NPR 151.156728
NZD 1.745963
OMR 0.38408
PAB 0.996752
PEN 3.472089
PGK 4.307306
PHP 60.550375
PKR 278.184401
PLN 3.72275
PYG 6516.824737
QAR 3.634057
RON 4.427304
RSD 101.684639
RUB 81.295743
RWF 1455.545451
SAR 3.752751
SBD 8.042037
SCR 15.03876
SDG 601.000339
SEK 9.47367
SGD 1.292704
SHP 0.750259
SLE 24.550371
SLL 20969.510825
SOS 569.659175
SRD 37.601038
STD 20697.981008
STN 21.220389
SVC 8.721147
SYP 110.527654
SZL 17.114027
THB 32.495038
TJS 9.523624
TMT 3.5
TND 2.938634
TOP 2.40776
TRY 44.440368
TTD 6.772336
TWD 32.044404
TZS 2571.564679
UAH 43.689489
UGX 3713.134988
UYU 40.344723
UZS 12155.385215
VES 467.928355
VND 26337.5
VUV 119.385423
WST 2.775484
XAF 568.149495
XAG 0.014291
XAU 0.000222
XCD 2.70255
XCG 1.796371
XDR 0.706596
XOF 568.149495
XPF 103.295656
YER 238.603589
ZAR 17.12001
ZMK 9001.203584
ZMW 18.763154
ZWL 321.999592
  • RBGPF

    -13.5000

    69

    -19.57%

  • JRI

    -0.2700

    11.8

    -2.29%

  • BCE

    -0.2200

    25.25

    -0.87%

  • BCC

    0.1400

    74.43

    +0.19%

  • RELX

    -0.1000

    31.97

    -0.31%

  • GSK

    -0.1000

    53.84

    -0.19%

  • RYCEF

    -0.5900

    14.65

    -4.03%

  • RIO

    0.8500

    86.64

    +0.98%

  • NGG

    -0.4800

    81.92

    -0.59%

  • VOD

    -0.1400

    14.49

    -0.97%

  • CMSC

    -0.0500

    22.77

    -0.22%

  • CMSD

    -0.0900

    22.66

    -0.4%

  • AZN

    5.0200

    188.42

    +2.66%

  • BTI

    0.3749

    57.8

    +0.65%

  • BP

    0.5100

    46.68

    +1.09%

FriskaAi and Dexcom Enter CGM Data Integration Agreement
FriskaAi and Dexcom Enter CGM Data Integration Agreement

FriskaAi and Dexcom Enter CGM Data Integration Agreement

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.

Text size:

FriskaAi is a physician-directed health and wellness platform that supports the management of diabetes and other chronic diseases by helping providers take an evidence-based approach to preventive care. The EHR-agnostic FriskaAi platform leverages advanced AI and mobile technology to generate personalized health insights and recommendations, empowering patients to take control of their health journey in partnership with their clinical team.

"Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine," says Shaji Nair, CEO of FriskaAi. "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."

Dexcom CGMs use a small, wearable sensor to continuously measure and send glucose levels wirelessly to a smart device or receiver in real-time, without the need for fingerpricks. Dexcom CGMs also offer a suite of customizable alerts that can warn of high or low glucose levels and send predictive alerts to help users spend more time in range.

The FriskaAi mobile app securely integrates with Dexcom CGMs and other smart devices, as well as health apps, for analysis by the powerful HIPAA-compliant FriskaAi platform. That data, along with other clinical data and studies, is continuously monitored by sophisticated AI-powered algorithms that alert the patient when action is recommended and generate actionable reports for use by the clinician at the point of care to inform care decisions.

Aggregated health data is also analyzed within the FriskaAI platform to help physicians identify trends and risks within their patient populations, enabling more proactive and preventive care strategies.

About FriskaAi

FriskaAi is a powerful AI-enabled EHR-agnostic platform that helps physicians and other providers take an evidence-based approach to preventive care. The physician-initiated platform leverages advanced AI- and mobile technology to provide patients with personalized health insights and recommendations, empowering them to take control of their health journey in partnership with their clinical team. This aggregated health data, including information from patients' glucometers, other smart devices, and health apps, is continuously analyzed by advanced evidence-based algorithms that alert the patient when action is needed and provide clinicians with actionable reports to inform care decisions. FriskaAi also supports population health strategies by analyzing aggregated health data to identify trends and risks within a defined patient population. For more information, visit www.friska.ai.

Media Contact:
Michele Nachum
NPC Creative Services
[email protected]

SOURCE: FriskaAi



View the original press release on ACCESS Newswire

X.Silva--TFWP